Skip to content

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders: A Mood Resilience Trial

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01216982
Enrollment
256
Registered
2010-10-07
Start date
2010-11-30
Completion date
2011-06-30
Last updated
2011-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Combat Disorders, Depression, Mood Disorders, Stress Disorders

Keywords

Mood Disorders, Depression, Combat Disorders, Stress Disorders, Fatty Acids, Omega-3, Military Personnel, Docosahexaenoic Acids/*therapeutic use, Eicosapentaenoic Acid/*therapeutic use

Brief summary

Stress-related disorders are among the most prevalent and expensive medical consequences of participation in military operations. Omega-3 fatty acids EPA/DHA derived from fish oil are known to benefit both neuronal development in the young, and cognition and mood in various populations. It is possible that soldiers receiving Omega-3 EPA/DHA will exhibit significantly higher cognitive performance, better affect/mood state, and less combat stress symptomatology compared to the placebo after 12 weeks of supplementation. A goal would be to reduce the prevalence of combat stress injuries in military personnel.

Interventions

DRUGLovaza, omega-3 fatty acid ethyl ester

Three 1g capsules/day for three months; this corresponds to a total of 2520mg EPA+DHA/day

DRUGPlacebo, visually identical to Lovaza

Three 1g corn oil capsules/day for three months

Sponsors

GlaxoSmithKline
CollaboratorINDUSTRY
United States Department of Defense
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* US Army deployed personnel * score on a mood questionnaire

Exclusion criteria

* currently consume omega-3 fish oil supplements * are currently taking antidepressant or other medications for psychiatric purposes * pregnant * known fish or shellfish allergy

Design outcomes

Primary

MeasureTime frameDescription
primary psychometric assessment battery3 monthsSpecific components include: Zung Depression Scale (ZDS) Zung Anxiety Scale (ZAS) Pittsburgh Sleep Quality Index (PSQI) Epworth Sleepiness Scale (ESS)
omega-3 fatty acid status3 monthsfinger-prick blood spot is collected for determination of fatty acid composition and profile.

Secondary

MeasureTime frameDescription
secondary psychometric assessment battery3 monthsThis battery will generate index scores in the area of: Memory, Psychomotor Speed, Reaction Time, Cognitive Flexibility, and Complex Attention. It will also include the Alcohol Use Identification Test (AUdIT). Military-specific components include Post-Deployment Health Assessment (PDHA), Neurobehavioral Symptom Inventory (NSI), Combat Exposure Scale (CES), and parts of the Deployment Risk and Resilience Inventory (edited).

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026